[EN] PKB INHIBITORS AS ANTI-TUMOR AGENTS<br/>[FR] INHIBITEURS DE LA PKB UTILISES COMME AGENTS ANTITUMORAUX
申请人:IMCLONE SYSTEMS INC
公开号:WO2005007099A2
公开(公告)日:2005-01-27
The invention is directed to biaryl compounds with two six membered rings fused wherein at least one six membered ring is substituted with a thiophenyl or furanyl ring. Useful in the inhibition of PKB kinase, the treatment of cancer, or the inhibition of tumor growth.
Transition Metal-Free Heteroarylation of Quinoxaline: Construction of Heteroaryl-Fused Phenazines by Oxidative Coupling
作者:Sefa Uçar、Arif Daştan
DOI:10.1021/acs.joc.0c02252
日期:2020.12.4
method for the construction of heteroaryl-fused phenazines was developed via PIFA-BF3·Et2O-mediated oxidativecoupling of di-heteroarylated quinoxalines for the first time. Synthesis of mono- and di-heteroarylation of quinoxaline was performed effectively using only LiTMP reagent under transitionmetal-free conditions and without the use of halogen-containing starting compounds. In addition, nonsymmetrical